Google DeepMind developed AlphaGenome, an AI model that processes DNA sequences up to one million base pairs long and predicts molecular properties related to gene regulation, including the effects of individual variants. The supplied DeepMind announcement establishes the underlying model, while secondary snippets describe its research preview and subsequent release. The case’s evidence titles identify an AlphaGenome Atlas release, but the supplied web snippets do not establish the Atlas’s coverage, availability, or precomputed lookup functionality; replacing per-variant inference with lookup remains an unverified claim here.
The proposed lookup-over-inference workflow would resemble Scott’s Batch Processing position, but the supplied grounding does not establish that AlphaGenome Atlas actually provides it; even if verified, that alone would be a cross-domain example, not an extension of his claim or a demonstrated impact on his projects. No supplied radar page tracks this same release, and the evidence does not yet support a consequential convergence or dated-receipts opportunity.
queries asked of Scott's wikis
- precomputed predictions versus on-demand inference economics
- batch inference caching reusable knowledge artifacts
- AI models packaged as queryable datasets
- research workflows prediction-based prioritization validation
- lookup versus model calls knowledge system architecture
2026-09-13T11:21:29Z
The latest personal-use headline shares an author and external link with the earlier AlphaGenome trial submission, so it adds neither independent adoption evidence nor reported results. It still does not establish Atlas use or validate the proposed lookup-over-inference workflow.
2026-09-13T11:21:22Z
evidence attached: hn.story.49682364 — shared external link with case evidence
2026-09-11T19:35:06Z
The newly attached headline repeats the nine-billion-variant claim without supplying methods, access details, or results; another listing is not an independent validation of Atlas’s lookup workflow. The case remains a low-relevance precomputation example, not demonstrated workflow savings or biological utility.
2026-09-11T19:22:13Z
evidence attached: hn.story.49624717 — This independently points to the same AlphaGenome Atlas episode and supports its claimed precomputed variant-effect lookup capability.
2026-09-11T15:30:57Z
The new submission's title claims a personal trial of AlphaGenome, but the supplied evidence contains neither the account nor its results and does not establish use of Atlas. It therefore does not corroborate the lookup workflow or demonstrate practical benefit.
2026-09-11T15:22:04Z
evidence attached: hn.story.49659696 — This hands-on use provides contextual evidence about AlphaGenome’s practical value for interpreting individual genetic variants.
2026-09-10T04:24:23Z
The refreshed comments add an intention to use Atlas, not demonstrated adoption or a measured workflow benefit. This remains a cross-domain precomputation example; neither enthusiasm nor unsupported performance objections establish its practical utility or change Scott’s engineering decisions.
2026-09-10T03:26:18Z
The new reader account makes the proposed precompute-and-lookup workflow more specific, but remains testimony about the same release rather than independent implementation or validation. It sharpens the distinction between cheaper access to predictions and demonstrated biological usefulness, without changing the case’s low relevance to Scott’s engineering decisions.
2026-09-10T01:22:25Z
evidence attached: reddit.post.1wc3vya — The post materially contextualizes AlphaGenome Atlas by distinguishing its lookup utility from experimentally validated biological measurements.
2026-09-09T14:24:00Z
evidence attached: reddit.post.1wbmc7a — shared external link with case evidence
2026-09-09T13:32:43Z
The refreshed comments add no substantive evidence beyond the existing release testimony and untested performance objections. Atlas remains a cross-domain precomputation example, with neither independent workflow validation nor a new consequence for Scott’s tooling decisions; lengthen the review cadence.
2026-09-09T10:24:40Z
The refreshed discussion remains repetitive amplification, with no verified access terms, independent implementation or substantiated evaluation of Atlas’s lookup utility. The reported artifact remains a cross-domain precomputation example rather than a development affecting Scott’s engineering decisions; further engagement-only checks add little value.
2026-09-09T03:26:29Z
The refreshed comments add no substantiated implementation, evaluation or access change; objections about model accuracy still do not test the value of the precomputed Atlas. The reported release remains a cross-domain precomputation example, without new consequences for Scott’s engineering decisions.
2026-09-09T02:26:11Z
The refreshed discussion remains amplification of the reported release, not a new implementation, verified access change or substantiated evaluation. Atlas remains a plausible cross-domain precomputation example; repeated discussion does not strengthen its bearing on Scott’s engineering decisions.
2026-09-08T23:24:51Z
The refreshed discussion adds no substantiated evaluation, implementation or access change; praise and model-performance objections do not independently test the Atlas’s lookup utility. The reported release remains a cross-domain precomputation example, with no new bearing on Scott’s engineering decisions.
2026-09-08T21:46:29Z
The refreshed discussion is repetitive amplification, with no independent implementation or substantiated evaluation of the Atlas. The proposed lookup-over-inference workflow remains a potentially useful cross-domain example, not new evidence affecting Scott’s engineering decisions.
2026-09-08T20:32:32Z
The refreshed discussion adds an unsupported claim that AlphaGenome offers little improvement over Borzoi, not a comparative evaluation; model accuracy and the utility of a precomputed Atlas remain separate questions. No independent implementation, verified access change or demonstrated workflow benefit has emerged, leaving the case a low-relevance cross-domain example.
2026-09-08T18:23:30Z
The refreshed discussion introduces a specific concern about conservation-derived benchmark labels, but supplies no supporting analysis; it is a validation question, not counterevidence establishing failure. The release remains plausible testimony about a precomputed research artifact, with no new implementation or verified access change that alters Scott’s engineering decisions.
2026-09-08T17:42:53Z
The refreshed discussion raises commercial-use restrictions and personal-genome applications as questions, not verified access terms or demonstrated uses. It adds no independent validation of the Atlas lookup workflow, so this remains a cross-domain precomputation example rather than evidence affecting Scott’s engineering decisions.
2026-09-08T16:43:17Z
The added HN listing strengthens confidence that the Atlas announcement occurred, but does not supply independent validation of the lookup workflow; the earlier attachment rationale overstates what its empty body and title establish. Coverage, access terms and practical utility remain unsettled, leaving this a cross-domain precomputation example rather than a change to Scott’s engineering decisions.
2026-09-08T16:23:24Z
evidence attached: hn.story.49610641 — This first-party DeepMind announcement independently corroborates the AlphaGenome Atlas artifact and its lookup-based genomics workflow.
2026-09-08T15:37:39Z
The refreshed discussion adds unverified academic-access and clinical-use anecdotes, not independent evidence that the Atlas delivers the proposed lookup workflow. Both listings and the reconstructed announcement still trace to the same release; coverage, access terms and downstream utility remain unsettled, leaving this a cross-domain example rather than a change to Scott’s engineering decisions.
2026-09-08T15:33:11Z
grounded: novel/low — The proposed lookup-over-inference workflow would resemble Scott’s Batch Processing position, but the supplied grounding does not establish that AlphaGenome Atl
2026-09-08T15:30:56Z
case created — Both objects trace to one first-party release, whose precomputed research artifact is concrete even though downstream utility is not yet established.